These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 22300789)

  • 1. mGluR3 and not mGluR2 receptors mediate the efficacy of NAAG peptidase inhibitor in validated model of schizophrenia.
    Olszewski RT; Bzdega T; Neale JH
    Schizophr Res; 2012 Apr; 136(1-3):160-1. PubMed ID: 22300789
    [No Abstract]   [Full Text] [Related]  

  • 2. NAAG peptidase inhibitors block cognitive deficit induced by MK-801 and motor activation induced by d-amphetamine in animal models of schizophrenia.
    Olszewski RT; Janczura KJ; Ball SR; Madore JC; Lavin KM; Lee JC; Lee MJ; Der EK; Hark TJ; Farago PR; Profaci CP; Bzdega T; Neale JH
    Transl Psychiatry; 2012 Jul; 2(7):e145. PubMed ID: 22850437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine and dizocilpine induced behaviors reduced by N-acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors.
    Olszewski RT; Wegorzewska MM; Monteiro AC; Krolikowski KA; Zhou J; Kozikowski AP; Long K; Mastropaolo J; Deutsch SI; Neale JH
    Biol Psychiatry; 2008 Jan; 63(1):86-91. PubMed ID: 17597589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAAG peptidase inhibition reduces locomotor activity and some stereotypes in the PCP model of schizophrenia via group II mGluR.
    Olszewski RT; Bukhari N; Zhou J; Kozikowski AP; Wroblewski JT; Shamimi-Noori S; Wroblewska B; Bzdega T; Vicini S; Barton FB; Neale JH
    J Neurochem; 2004 May; 89(4):876-85. PubMed ID: 15140187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NAAG Peptidase Inhibitors Act via mGluR3: Animal Models of Memory, Alzheimer's, and Ethanol Intoxication.
    Olszewski RT; Janczura KJ; Bzdega T; Der EK; Venzor F; O'Rourke B; Hark TJ; Craddock KE; Balasubramanian S; Moussa C; Neale JH
    Neurochem Res; 2017 Sep; 42(9):2646-2657. PubMed ID: 28285415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Group II mGluR agonist LY354740 and NAAG peptidase inhibitor effects on prepulse inhibition in PCP and D-amphetamine models of schizophrenia.
    Profaci CP; Krolikowski KA; Olszewski RT; Neale JH
    Psychopharmacology (Berl); 2011 Jul; 216(2):235-43. PubMed ID: 21327758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of N-acetylaspartylglutamate (NAAG) peptidase inhibition on release of glutamate and dopamine in prefrontal cortex and nucleus accumbens in phencyclidine model of schizophrenia.
    Zuo D; Bzdega T; Olszewski RT; Moffett JR; Neale JH
    J Biol Chem; 2012 Jun; 287(26):21773-82. PubMed ID: 22570482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action?
    Ghose S; Gleason KA; Potts BW; Lewis-Amezcua K; Tamminga CA
    Am J Psychiatry; 2009 Jul; 166(7):812-20. PubMed ID: 19487395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clozapine reverses schizophrenia-related behaviours in the metabotropic glutamate receptor 5 knockout mouse: association with N-methyl-D-aspartic acid receptor up-regulation.
    Gray L; van den Buuse M; Scarr E; Dean B; Hannan AJ
    Int J Neuropsychopharmacol; 2009 Feb; 12(1):45-60. PubMed ID: 18593507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3.
    Berent-Spillson A; Robinson AM; Golovoy D; Slusher B; Rojas C; Russell JW
    J Neurochem; 2004 Apr; 89(1):90-9. PubMed ID: 15030392
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The astrocyte surface NAAG receptor and NAAG peptidase signaling complex as a therapeutic target.
    Baslow MH
    Drug News Perspect; 2008 Jun; 21(5):251-7. PubMed ID: 18596989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local administration of N-acetylaspartylglutamate (NAAG) peptidase inhibitors is analgesic in peripheral pain in rats.
    Yamamoto T; Saito O; Aoe T; Bartolozzi A; Sarva J; Zhou J; Kozikowski A; Wroblewska B; Bzdega T; Neale JH
    Eur J Neurosci; 2007 Jan; 25(1):147-58. PubMed ID: 17241276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of NAAG peptidase inhibitor 2-PMPA in model chronic pain - relation to brain concentration.
    Nagel J; Belozertseva I; Greco S; Kashkin V; Malyshkin A; Jirgensons A; Shekunova E; Eilbacher B; Bespalov A; Danysz W
    Neuropharmacology; 2006 Dec; 51(7-8):1163-71. PubMed ID: 16926034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutual activation of glutamatergic mGlu
    Cieślik P; Woźniak M; Rook JM; Tantawy MN; Conn PJ; Acher F; Tokarski K; Kusek M; Pilc A; Wierońska JM
    Psychopharmacology (Berl); 2018 Oct; 235(10):2897-2913. PubMed ID: 30054675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mGluR3 knockout mice show a working memory defect and an enhanced response to MK-801 in the T- and Y-maze cognitive tests.
    Lainiola M; Procaccini C; Linden AM
    Behav Brain Res; 2014 Jun; 266():94-103. PubMed ID: 24631392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-PMPA, a NAAG peptidase inhibitor, attenuates magnetic resonance BOLD signals in brain of anesthetized mice: evidence of a link between neuron NAAG release and hyperemia.
    Baslow MH; Dyakin VV; Nowak KL; Hungund BL; Guilfoyle DN
    J Mol Neurosci; 2005; 26(1):1-15. PubMed ID: 15968081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biphenyl-indanone A, a positive allosteric modulator of the metabotropic glutamate receptor subtype 2, has antipsychotic- and anxiolytic-like effects in mice.
    Galici R; Jones CK; Hemstapat K; Nong Y; Echemendia NG; Williams LC; de Paulis T; Conn PJ
    J Pharmacol Exp Ther; 2006 Jul; 318(1):173-85. PubMed ID: 16608916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prefrontal dysfunction and a monkey model of schizophrenia.
    Mao P; Cui D; Zhao XD; Ma YY
    Neurosci Bull; 2015 Apr; 31(2):235-41. PubMed ID: 25822218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia.
    Fraley ME
    Expert Opin Ther Pat; 2009 Sep; 19(9):1259-75. PubMed ID: 19552508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
    Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.